Patent · US Active

Agent for suppressing expression of dominant allele

US8946185B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2011
Grant dateFeb 3, 2015
Priority date
Expiry dateJun 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An agent for selectively suppressing the expression of a dominant allele while allowing expression of wild-type or desired alleles and methods for using the agent are described. The RNAi agent has a structure obtained by assigning a dominant point mutation in the targeted allele as a standard point, setting a base length from the standard point to the 5′ end to a predetermined length, and introducing one mismatch base differing from the target sequence to a predetermined position downstream from the standard point.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.